Drug · DIN 02304104
TORISEL
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 11, 2011; first marketed January 11, 2008.
- Drug Identification Number (DIN)
- 02304104
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Temsirolimus L01EG01
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TEMSIROLIMUS | 25 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 29, 2010: NOC 11760New Drug Submission (NDS) · Manufacturer name change
- December 21, 2007: NOC 9263New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “torisel”. A notice may cover another product or only some lots: read it to see what it covers.
- Torisel (2014-10-06)October 22, 2014 · Drugs · Product safety · Type III
- Archived - Association between TORISEL (temsirolimus) concentrate for injection and hypersensitivity/infusion reactions - For the PublicAugust 11, 2008 · Drugs
- Association between Torisel (temsirolimus) concentrate for injection and hypersensitivity/infusion reactions- For Health ProfessionalsAugust 11, 2008 · Drugs